SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-050535
Filing Date
2024-04-30
Accepted
2024-04-30 16:15:51
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lyra-20240331.htm   iXBRL 10-Q 1913622
2 EX-10.1 lyra-ex10_1.htm EX-10.1 53488
3 EX-10.2 lyra-ex10_2.htm EX-10.2 51851
4 EX-31.1 lyra-ex31_1.htm EX-31.1 15696
5 EX-31.2 lyra-ex31_2.htm EX-31.2 15690
6 EX-32.1 lyra-ex32_1.htm EX-32.1 8747
7 EX-32.2 lyra-ex32_2.htm EX-32.2 8736
8 EX-99.1 lyra-ex99_1.htm EX-99.1 39435
  Complete submission text file 0000950170-24-050535.txt   7405699

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lyra-20240331.xsd EX-101.SCH 1168131
71 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20240331_htm.xml XML 1006610
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39273 | Film No.: 24897455
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)